Clinical Trial Update: FAU in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating FAU in patients with advanced solid tumors or lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma
• Angioimmunoblastic T-cell Lymphoma
• Burkitt Lymphoma
• Cutaneous B-cell Non-hodgkin Lymphoma
• Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
• Extranodal Nk T-cell Lymphoma Nasal Type
• Lymphomatoid Granulomatosis
• Nodal Marginal Zone B-cell Lymphoma

Drugs mentioned

• FAU

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma | Phase 1 | Status: COMPLETED